TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy

TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy

Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer associated with a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target-based therapeutic options are approved for other cancers, only limited therapeutic options are available for TNBC. Cel...

Full description

Bibliographic Details
Main Authors: Desh Deepak Singh, Dharmendra Kumar Yadav
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomedicines
Subjects:
triple-negative breast cancer
therapeutic target
signaling pathway
clinical trial
Online Access:https://www.mdpi.com/2227-9059/9/8/876

Internet

https://www.mdpi.com/2227-9059/9/8/876

Similar Items